Ultra-Purified Microbial Fractions: A New Frontier in FMT-Derived Therapeutics

  • Showcase a proprietary manufacturing process that isolates microbial fractions while discarding faecal material
  • Present preclinical data in infectious disease, melanoma, and colorectal cancer models
  • Prepare for IND submission and clinical trial initiation to validate cross-indication potential